Free Trial

Harvard Bioscience (HBIO) Insider Trading & Ownership

Harvard Bioscience logo
$2.16 +0.11 (+5.37%)
(As of 11/20/2024 ET)

Harvard Bioscience (NASDAQ:HBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$90,500.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get HBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Harvard Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HBIO Insider Buying and Selling by Quarter

Harvard Bioscience Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/13/2024James W GreenCEOBuy10,000$2.91$29,100.00  
6/6/2024James W GreenCEOBuy20,000$3.07$61,400.00  
(Data available from 1/1/2013 forward)

HBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Harvard Bioscience includes Alan I Edrick, Bertrand Loy, and James W Green. Learn more on insiders at HBIO.

9.00% of Harvard Bioscience stock is owned by insiders. Learn more on HBIO's insider holdings.

The following insiders have purchased HBIO shares in the last 24 months: Alan I Edrick ($36,867.36), and James W Green ($253,400.00).

Insiders have purchased a total of 88,808 HBIO shares in the last 24 months for a total of $290,267.36 bought.

Harvard Bioscience Key Executives

  • Mr. James W. GreenMr. James W. Green (Age 66)
    President, CEO & Chairman
    Compensation: $619.48k
    2 recent trades
  • Ms. Jennifer Cote CPA (Age 52)
    CGMA, CFO & Treasurer
    Compensation: $361.27k
  • Mr. David Balcom
    Senior Vice President of Operations
  • Mr. John J. Fry (Age 63)
    Chief Legal Counsel & Corporation Secretary
  • Mr. Ryan Wallace
    Senior Vice President of Global Sales
  • Ms. Lori Packer
    Vice President of Global People Operations
  • David Sirois
    Director of Corporate Accounting & SEC Reporting


This page (NASDAQ:HBIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners